Inhibition in the progression of preinvasive lung cancer by pomegranate.

石榴抑制浸润前肺癌的进展。

基本信息

  • 批准号:
    8231278
  • 负责人:
  • 金额:
    $ 7.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2013-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Lung cancer is the most common cancer in the world and tobacco smoking is the major risk factor, accounting for about 90% of the cases. Early detection of premalignant lesions or tumors appears to be an efficient approach for reducing the morbidity and mortality from lung cancer because the survival of early stage lung cancer patients is much better than that of patients with advanced cancers. Although tobacco smoking accounts for the majority of lung cancer, approximately 10% of patients with lung cancer in the United States are victims of exposure to second hand tobacco smoke. In addition, the individuals who have quit smoking (ex- smokers) are another group of people who are also at risk for developing lung cancer. Therefore, identifying novel mechanism based preventive approaches for tobacco smoke-induced lung cancer through the use of dietary substances is a highly desirable goal. The activation of mammalian targets of rapamycin (mTOR) signaling and cyclooxygenase (COX)-2 has long been associated with malignant transformation and has emerged as important cancer chemopreventive/chemotherapeutic targets. Retinoids are required for proper differentiation of lung and upper airway epithelium, and loss of expression of retinoic acid receptor (RAR)-¿ is characteristic of many lung cancers. Based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis, pomegranate fruit extract (PFE) was found to contain anthocyanins (such as delphinidin, cyanidin and pelargonidin) and several hydrolysable tannins (such as punicalin, pedunculagin, punicalagin, gallagic and ellagic acid esters of glucose). We have recently reported that PFE caused inhibition of prosurvival signaling pathways in human lung carcinoma A549 cells and inhibited tumor growth in athymic nude mice and A/J mice. Capitalizing on our compelling studies in cell-culture and in-vivo work, through this proposal, it is hypothesized that PFE will inhibit/delay lung tumor progression of adenomas to adenocarcinomas by suppressing mTOR signaling and expression of COX-2 as well as induction of retinoic acid receptor (RAR)-¿ in lungs of A/J mice. Studies will also be conducted to examine the effect of PFE on these targets in human non-small cell lung cancer cells. HEALTH RELEVANCE: Verification of this hypothesis could be extremely useful to establish the usefulness of PFE for the development of novel therapeutic approaches in improving the quality of life of early stage lung cancer patients and individuals who are ex- smokers.
描述(由申请人提供): 肺癌是世界上最常见的癌症,烟草吸烟是主要危险因素,约占病例的90%。早期发现前病变或肿瘤似乎是降低肺癌发病率和死亡率的有效方法,因为早期肺癌患者的存活比晚期癌症患者的生存率要好得多。尽管烟草吸烟占大部分肺癌,但美国大约10%的肺癌患者在暴露于二手烟草烟雾中令人惊讶。此外,戒烟的人(吸烟者)是另一组患有肺癌风险的人。因此,通过使用饮食物质来确定基于机制的新型预防方法是烟草烟雾诱导的肺癌。雷帕霉素(MTOR)信号传导和环氧酶(COX)-2的哺乳动物靶标长期以来一直与恶性转化有关,并且已经成为重要的癌症化学预防/化学治疗靶标。类维生素类似于肺和上呼吸道上皮的适当分化所必需的,视网膜上的肺酸受体(RAR)的表达丧失是许多肺癌的特征。 Based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis, pomegranate fruit extract (PFE) was found to contain anthocyanins (such as delphinidin, cyanidin and pelagonidin) and several hydrolysable tannins (such as punicalin, pedunculagin, punicalagin, gallagic and ellagic acid esters of葡萄糖)。我们最近报道说,PFE在人类肺癌A549细胞中引起了抑制PROVIVAL信号通路,并抑制了胸骨裸鼠和A/J小鼠的肿瘤生长。通过这项提案来利用我们在细胞培养和体内工作中的引人注目的研究,可以假设PFE将通过抑制Cox-2的MTOR信号传导和表达Cox-2的MTOR信号传导和视黄酸受体(RAR)的诱导(RAR) - 在A/J MICE的肺中抑制腺癌的肺肿瘤进展。还将进行研究以检查PFE对人类非小细胞肺癌细胞中这些靶标的影响。健康相关性:对这一假设的验证对于建立PFE在开发新型治疗方法方面的有用性对于改善早期肺癌患者和前吸烟者的个人的生活质量而言非常有用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dietary agents for prevention and treatment of lung cancer.
  • DOI:
    10.1016/j.canlet.2015.01.038
  • 发表时间:
    2015-04-10
  • 期刊:
  • 影响因子:
    9.7
  • 作者:
    Khan, Naghma;Mukhtar, Hasan
  • 通讯作者:
    Mukhtar, Hasan
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGHMA KHAN其他文献

NAGHMA KHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGHMA KHAN', 18)}}的其他基金

Inhibition in the progression of preinvasive lung cancer by pomegranate.
石榴抑制浸润前肺癌的进展。
  • 批准号:
    8112424
  • 财政年份:
    2011
  • 资助金额:
    $ 7.43万
  • 项目类别:

相似国自然基金

基于多重精准选择性碳氢官能化合成策略的抗A549/HepG2活性先导化合物发现及其作用靶标研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目
E3泛素连接酶NEDL2泛素化修饰PTEN参与肺癌发生的分子机制研究
  • 批准号:
    81602412
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
内蒙古白云鄂博稀土矿区大气可吸入颗粒物对A549细胞毒理研究
  • 批准号:
    81473017
  • 批准年份:
    2014
  • 资助金额:
    66.0 万元
  • 项目类别:
    面上项目
一个肺腺癌相关新lncRNA LOC100132354的生物学功能及其分子机制研究
  • 批准号:
    81401736
  • 批准年份:
    2014
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
用于识别癌细胞A549的磁共振和荧光双功能探针的研究
  • 批准号:
    21305156
  • 批准年份:
    2013
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Optical Surface Applicator Light Dosimetry for Ruthenium-based Photosensitizer Mediated Intraoperative Photodynamic Therapy
用于钌基光敏剂介导的术中光动力治疗的光学表面照射器光剂量测定
  • 批准号:
    10303270
  • 财政年份:
    2021
  • 资助金额:
    $ 7.43万
  • 项目类别:
KY INBRE Admin Supplement: The Role of Platinum Leaving Ligands in Chemo-immunotherapeutic Resistance in Lung Cancer Models
KY INBRE 管理补充:铂离去配体在肺癌模型化疗免疫治疗耐药中的作用
  • 批准号:
    10399834
  • 财政年份:
    2021
  • 资助金额:
    $ 7.43万
  • 项目类别:
Optical Surface Applicator Light Dosimetry for Ruthenium-based Photosensitizer Mediated Intraoperative Photodynamic Therapy
用于钌基光敏剂介导的术中光动力治疗的光学表面照射器光剂量测定
  • 批准号:
    10454364
  • 财政年份:
    2021
  • 资助金额:
    $ 7.43万
  • 项目类别:
MKP1, VSMC, and Vascular Remodeling
MKP1、VSMC 和血管重塑
  • 批准号:
    10206241
  • 财政年份:
    2018
  • 资助金额:
    $ 7.43万
  • 项目类别:
Mechanisms that control the progression from premalignant lesions to adenocarcinomas in the lung
控制肺癌前病变进展为腺癌的机制
  • 批准号:
    9305499
  • 财政年份:
    2017
  • 资助金额:
    $ 7.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了